20 participants
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-30
- Start Date:
- 2022-07-13
- Completion:
- 2026-12-01
Conditions
- Sickle Cell Disease
Interventions
- DRUG
- PROCEDURE
- RADIATION
No Results Yet